BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
Citi
Cipla
Colorcon
Fuji
Novartis
US Army
Queensland Health
McKesson

Generated: January 18, 2018

DrugPatentWatch Database Preview

PHENTERMINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentermine hydrochloride and what is the scope of phentermine hydrochloride freedom to operate?

Phentermine hydrochloride
is the generic ingredient in eleven branded drugs marketed by Teva, Glaxosmithkline, Ferndale Labs, Shire Richwood, Mast Mm, Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Ken Lifescience, Kvk Tech, Lannett, Lannett Holdings Inc, Mikah Pharma, Sandoz, Sun Pharm Industries, Tg United Inc, Upsher-smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms Usa Inc, Citius Pharms, Avanthi Inc, Actavis Elizabeth, Ingenus Pharms Nj, Kvk Tech Inc, Polygen Pharms, Prinston Inc, Sandoz Inc, Sun Pharm Inds Inc, Solvay, and Vivus, and is included in one hundred NDAs. There are thirteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Phentermine hydrochloride has fourteen patent family members in ten countries.

There are seventeen drug master file entries for phentermine hydrochloride. Forty-six suppliers are listed for this compound.
Summary for PHENTERMINE HYDROCHLORIDE
Pharmacology for PHENTERMINE HYDROCHLORIDE

US Patents and Regulatory Information for PHENTERMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-001 Jul 17, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Zydus Pharms Usa Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 204663-003 Jun 28, 2017 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 085671-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-003 Jul 17, 2012 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 088605-001 Sep 28, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Invagen Pharms PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 202858-002 Feb 14, 2014 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-004 Jul 17, 2012 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-001 Jul 17, 2012 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Duramed Pharms Barr PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088948-001 Apr 25, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 088917-001 Jul 17, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for PHENTERMINE HYDROCHLORIDE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
US Department of Justice
Chinese Patent Office
Mallinckrodt
QuintilesIMS
Cipla
Chubb
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot